VEGFA and bronchopulmonary dysplasia: Finally, we noted a significant increase in alveolar size upon VEGF-induction in room air (from postnatal or PN day 5–14), after exposure to hyperoxia from PN1-4 (the mouse broncho-pulmonary dysplasia or BPD model [5, 6]), suggesting a detrimental response to VEGF treatment.